您的位置: 首页 > 2018年9月 第49卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

COPD合并肺动脉高压疾病危险因素分析

Analysis of risk factors of pulmonary hypertension associated with COPD

来源期刊: 广州医药 | 74-77 发布时间:2021-11-29 收稿时间:2025/11/13 17:18:59 阅读量:38
作者:
关键词:
肺动脉高压COPD危险因素
Pulmonary hypertension (PH)COPDRisk factors
DOI:
10.3969/j.issn.1000-8535.2018.05.018
收稿时间:
2018-07-25 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)合并肺动脉高压(pulmonary hypertention,PH)的危险因素。方法 回顾2014年1月—2015年1月广州医科大学附属第一医院住院患者55例,经心脏彩色多普勒超声测量肺动脉收缩压(PASP),分为:轻度组(36≤PASP<50 mmHg),中度组(51≤PASP<70 mmHg)和重度组(PASP≥70 mmHg),分析比较三组临床特征,危险因素采用单因素及多因素Logistic回归分析。结果 年龄(75.3±11.6)岁,PASP为(52.6±15.1)mmHg。单因素分析中-重度PH与年龄、HCT、PaCO2、PaO2、D-二聚体有关;多因素Logistic回归分析确定3项危险因素:HCT[比值比(OR)=51.82,95% CI: 2.34~1149.02],RV(OR=4.53,95% CI: 2.83~7.27),及PaCO2(OR=1.02,95% CI: 1.00~1.03)。结论 呼吸病相关PH多为轻-中度,高水平的HCT、RV直径及PaCO2提示PH病情较重。
Objective To analyze the clinical risk factors of pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease(COPD). Methods A total of 55 hospitalized patients from 2014 to 2015 were enrolled in the study and were classified into three groups according to pulmonary artery systolic pressure (PASP) with echocardiography as follows: the mild group (36≤PASP<50 mmHg), the moderate group (51≤PASP<70 mmHg) and the severe group (PASP≥70 mmHg). Clinical data were recorded and retrospectively analyzed. Results The average age of all patients was (75.3±11.6)years. Echocardiography showed a mean PASP was 52.6±15.1 mmHg. Age, hematocrit (HCT), partial pressure of carbon dioxide (PaCO2), the oxygen partial pressure (PaO2), D-dimer and right ventricular (RV) diameter (>20 mm) were associated with moderate-to-severe PH on an univariate regression analysis, while RV (diameter >20 mm)[odds ratio (OR)=4.53, 95% CI: 2.83~7.27], HCT(OR=51.82, 95% CI: 2.34~1149.02) and PaCO2 (OR=1.02, 95% CI: 1.00-1.03), to these patients, were independent risk factors using the multiple logistic regression analysis. Conclusion PH related to respiratory diseases is mostly mild-to-moderate. Haemoptysis,high levels of RV diameter, HCT and PaCO2 suggest a serious condition of patients with PH related to chronic respiratory disease.
1、 SALAZAR VáZQUEZ B Y,CABRALES P,TSAI A G,et al.Nonlinear cardiovascular regulation consequent to changes in blood viscosity[J]. Clin Hemorheol Microcirc,2011,49(1-4):29-36. SALAZAR VáZQUEZ B Y,CABRALES P,TSAI A G,et al.Nonlinear cardiovascular regulation consequent to changes in blood viscosity[J]. Clin Hemorheol Microcirc,2011,49(1-4):29-36.
2、 SABATINE M S,MORROW D A,GIUGLIANO R,et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes[J]. Circulation,2005,14(8):2042-2049. SABATINE M S,MORROW D A,GIUGLIANO R,et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes[J]. Circulation,2005,14(8):2042-2049.
3、 BROWN D W, GILES W H, CROFT J B. Hematocrit and the risk of coronary heart disease mortality[J].American Heart Journal,2001,142(4):657-663. BROWN D W, GILES W H, CROFT J B. Hematocrit and the risk of coronary heart disease mortality[J].American Heart Journal,2001,142(4):657-663.
4、 CROXTON T L,BAILEY W C. Long-term oxygen treatment in chronic obstructive pulmonary disease:recommendations for future research:an NHLBl workshop report[J]. Am J Respir Crit Care Med,2006,174(4):373-378. CROXTON T L,BAILEY W C. Long-term oxygen treatment in chronic obstructive pulmonary disease:recommendations for future research:an NHLBl workshop report[J]. Am J Respir Crit Care Med,2006,174(4):373-378.
5、 CHAOUAT A, BUGNET A S, KADAOUI N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2005,172(2):189-194. CHAOUAT A, BUGNET A S, KADAOUI N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2005,172(2):189-194.
6、 MCLAUGHLIN V V, ARCHER S L, BADESCH D B, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension[J]. J Am Coll Cardiol,2009,53(17):1573-1619. MCLAUGHLIN V V, ARCHER S L, BADESCH D B, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension[J]. J Am Coll Cardiol,2009,53(17):1573-1619.
7、 廖方清,吕舜荣,吴海娟. 右室Tei指数在COPD合并肺动脉高压患者中的变化[J]. 现代医院,2014,14(7):78-82. 廖方清,吕舜荣,吴海娟. 右室Tei指数在COPD合并肺动脉高压患者中的变化[J]. 现代医院,2014,14(7):78-82.
8、 程春燕,张宏达,荆志成.抑郁影响肺血管重构病理生理学机制[J]. 中华内科杂志,2014,53(1):67-69. 程春燕,张宏达,荆志成.抑郁影响肺血管重构病理生理学机制[J]. 中华内科杂志,2014,53(1):67-69.
9、 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013修订版)[J]. 中华结核和呼吸杂志,2013,36(4):255-264. 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013修订版)[J]. 中华结核和呼吸杂志,2013,36(4):255-264.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录